A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Ozempic. Wegovy and other GLP-1 medications have been hailed as groundbreaking treatments for individuals struggling with ...
Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...